Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Apr;146(4):812–818.

Lymphocyte predominance Hodgkin's disease. Evidence for a kappa light chain-restricted monotypic B-cell neoplasm.

M H Stoler 1, G E Nichols 1, M Symbula 1, L M Weiss 1
PMCID: PMC1869259  PMID: 7717448

Abstract

Over the last decade, it has been noted that nodular lymphocytic and/or histiocytic predominance Hodgkin's disease (NLPHD) has clinical, histological, and immunophenotypical differences from classical Hodgkin's disease, but it is not clear whether NLPHD represents a B-cell neoplasm or merely an unusual B-lineage reactive condition. We evaluated 36 cases of LPHD (31 nodular, 5 diffuse) for evidence of B-cell clonality by immunohistochemistry for light-chain protein using polyclonal antibodies and microwave antigen retrieval, and by a highly sensitive in situ hybridization technique for light-chain mRNA using 3H-labeled antisense RNA probes. We found monotypic light-chain restriction for kappa protein in 36% of cases, with no clear predominance for either light-chain protein in the other cases. By in situ hybridization, 80% of the evaluable cases showed clear evidence of light-chain monotypsim, with 96% of cases monotypic for kappa mRNA and one case monotypic for lambda mRNA. In virtually all of these cases, the L&H cells were found to be monotypic, consistent with monoclonality. In about one-half of these cases, a small lymphocytic component was also found to be monotypic. Our data support the hypothesis that NLPHD and its rare diffuse variant represent a monotypic B-cell neoplasm, almost always of kappa light-chain type. NLPHD represents a neoplasm distinct from classical Hodgkin's disease.

Full text

PDF
813

Images in this article

815Figure 1
on p.815
816Figure 2
on p.816

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Algara P., Martinez P., Sanchez L., Villuendas R., Orradre J. L., Oliva H., Piris M. A. Lymphocyte predominance Hodgkin's disease (nodular paragranuloma)--a bcl-2 negative germinal centre lymphoma. Histopathology. 1991 Jul;19(1):69–75. doi: 10.1111/j.1365-2559.1991.tb00896.x. [DOI] [PubMed] [Google Scholar]
  2. Banks P. M., Chan J., Cleary M. L., Delsol G., De Wolf-Peeters C., Gatter K., Grogan T. M., Harris N. L., Isaacson P. G., Jaffe E. S. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992 Jul;16(7):637–640. doi: 10.1097/00000478-199207000-00001. [DOI] [PubMed] [Google Scholar]
  3. Chittal S. M., Alard C., Rossi J. F., al Saati T., Le Tourneau A., Diebold J., Delsol G. Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. Am J Surg Pathol. 1990 Nov;14(11):1024–1035. doi: 10.1097/00000478-199011000-00004. [DOI] [PubMed] [Google Scholar]
  4. Delabie J., Tierens A., Wu G., Weisenburger D. D., Chan W. C. Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood. 1994 Nov 15;84(10):3291–3298. [PubMed] [Google Scholar]
  5. Delsol G., Brousset P., Chittal S., Rigal-Huguet F. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease. Am J Pathol. 1992 Feb;140(2):247–253. [PMC free article] [PubMed] [Google Scholar]
  6. Hansmann M. L., Stein H., Fellbaum C., Hui P. K., Parwaresch M. R., Lennert K. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol. 1989 Dec;20(12):1169–1175. doi: 10.1016/s0046-8177(89)80007-3. [DOI] [PubMed] [Google Scholar]
  7. Hell K., Pringle J. H., Hansmann M. L., Lorenzen J., Colloby P., Lauder I., Fischer R. Demonstration of light chain mRNA in Hodgkin's disease. J Pathol. 1993 Oct;171(2):137–143. doi: 10.1002/path.1711710211. [DOI] [PubMed] [Google Scholar]
  8. Landaas T. O., Godal T., Halvorsen T. B. Characterization of immunoglobulins in Hodgkin cells. Int J Cancer. 1977 Nov 15;20(5):717–722. doi: 10.1002/ijc.2910200511. [DOI] [PubMed] [Google Scholar]
  9. Linden M. D., Fishleder A. J., Katzin W. E., Tubbs R. R. Absence of B-cell or T-cell clonal expansion in nodular, lymphocyte predominant Hodgkin's disease. Hum Pathol. 1988 May;19(5):591–594. doi: 10.1016/s0046-8177(88)80210-7. [DOI] [PubMed] [Google Scholar]
  10. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  11. Miettinen M., Franssila K. O., Saxén E. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer. 1983 Jun 15;51(12):2293–2300. doi: 10.1002/1097-0142(19830615)51:12<2293::aid-cncr2820511221>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  12. Momose H., Chen Y. Y., Ben-Ezra J., Weiss L. M. Nodular lymphocyte-predominant Hodgkin's disease: study of immunoglobulin light chain protein and mRNA expression. Hum Pathol. 1992 Oct;23(10):1115–1119. doi: 10.1016/0046-8177(92)90029-3. [DOI] [PubMed] [Google Scholar]
  13. Papadimitriou C. S., Stein H., Lennert K. The complexity of immunohistochemical staining pattern of Hodgkin and Sternberg-reed cells--demonstration of immunoglobulin, albumin, alpha1-antichymotrypsin and lysozyme. Int J Cancer. 1978 May 15;21(5):531–541. doi: 10.1002/ijc.2910210502. [DOI] [PubMed] [Google Scholar]
  14. Pinkus G. S., Said J. W. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen. Am J Pathol. 1985 Jan;118(1):1–6. [PMC free article] [PubMed] [Google Scholar]
  15. Pinkus G. S., Said J. W. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol. 1988 Nov;133(2):211–217. [PMC free article] [PubMed] [Google Scholar]
  16. Poppema S., Kaiserling E., Lennert K. Epidemiology of nodular paragranuloma (Hodgkin's disease with lymphocytic predominance, nodular). J Cancer Res Clin Oncol. 1979 Sep;95(1):57–63. doi: 10.1007/BF00411110. [DOI] [PubMed] [Google Scholar]
  17. Poppema S., Kaiserling E., Lennert K. Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology. 1979 Jul;3(4):295–308. doi: 10.1111/j.1365-2559.1979.tb03011.x. [DOI] [PubMed] [Google Scholar]
  18. Poppema S., Kaiserling E., Lennert K. Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol. 1979;31(3):211–225. doi: 10.1007/BF02889938. [DOI] [PubMed] [Google Scholar]
  19. Poppema S. The diversity of the immunohistological staining pattern of Sternberg-Reed cells. J Histochem Cytochem. 1980 Aug;28(8):788–791. doi: 10.1177/28.8.6777426. [DOI] [PubMed] [Google Scholar]
  20. Regula D. P., Jr, Hoppe R. T., Weiss L. M. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med. 1988 Jan 28;318(4):214–219. doi: 10.1056/NEJM198801283180404. [DOI] [PubMed] [Google Scholar]
  21. Ruprai A. K., Pringle J. H., Angel C. A., Kind C. N., Lauder I. Localization of immunoglobulin light chain mRNA expression in Hodgkin's disease by in situ hybridization. J Pathol. 1991 May;164(1):37–40. doi: 10.1002/path.1711640107. [DOI] [PubMed] [Google Scholar]
  22. Said J. W., Sassoon A. F., Shintaku I. P., Kurtin P. J., Pinkus G. S. Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction. Am J Pathol. 1991 Feb;138(2):261–264. [PMC free article] [PubMed] [Google Scholar]
  23. Schmid C., Sargent C., Isaacson P. G. L and H cells of nodular lymphocyte predominant Hodgkin's disease show immunoglobulin light-chain restriction. Am J Pathol. 1991 Dec;139(6):1281–1289. [PMC free article] [PubMed] [Google Scholar]
  24. Segal G. H., Shick H. E., Tubbs R. R., Fishleder A. J., Stoler M. H. In situ hybridization analysis of lymphoproliferative disorders. Assessment of clonality by immunoglobulin light-chain messenger RNA expression. Diagn Mol Pathol. 1994 Sep;3(3):170–177. [PubMed] [Google Scholar]
  25. Sheibani K., Tubbs R. R. Enzyme immunohistochemistry: technical aspects. Semin Diagn Pathol. 1984 Nov;1(4):235–250. [PubMed] [Google Scholar]
  26. Stein H., Hansmann M. L., Lennert K., Brandtzaeg P., Gatter K. C., Mason D. Y. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol. 1986 Sep;86(3):292–297. doi: 10.1093/ajcp/86.3.292. [DOI] [PubMed] [Google Scholar]
  27. Stoler M. H. In situ hybridization. Clin Lab Med. 1990 Mar;10(1):215–236. [PubMed] [Google Scholar]
  28. Sundeen J. T., Cossman J., Jaffe E. S. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy? Am J Surg Pathol. 1988 Aug;12(8):599–606. [PubMed] [Google Scholar]
  29. Timens W., Visser L., Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest. 1986 Apr;54(4):457–461. [PubMed] [Google Scholar]
  30. Veress B., Alafuzoff I. A retrospective analysis of clinical diagnoses and autopsy findings in 3,042 cases during two different time periods. Hum Pathol. 1994 Feb;25(2):140–145. doi: 10.1016/0046-8177(94)90269-0. [DOI] [PubMed] [Google Scholar]
  31. Weiss L. M., Chen Y. Y., Liu X. F., Shibata D. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol. 1991 Dec;139(6):1259–1265. [PMC free article] [PubMed] [Google Scholar]
  32. Weiss L. M., Warnke R. A., Sklar J., Cleary M. L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987 Nov 5;317(19):1185–1189. doi: 10.1056/NEJM198711053171904. [DOI] [PubMed] [Google Scholar]
  33. Weiss L. M., Warnke R. A., Sklar J. Clonal antigen receptor gene rearrangements and Epstein-Barr viral DNA in tissues of Hodgkin's disease. Hematol Oncol. 1988 Jul-Sep;6(3):233–238. doi: 10.1002/hon.2900060306. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES